Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 12/1/00 → 11/30/01 |
Funding
- Genetics Institute
A Phase IV, Open-Label, Multicenter, Randomized Study of NEUMEGAR (Recombinant Human Interleukin Eleven Growth Factor, rhIL-11) in Patients with Lymphoma and Chemotherapy
- Fleischman, Roger (PI)